Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Podobne zapisy

• Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
  od: Ben-Shlomo, Anat, i wsp.
  Wydane: (2009)
• Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
  od: Ben-Shlomo, Anat, i wsp.
  Wydane: (2009)
• Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis
  od: Ben-Shlomo, Anat, i wsp.
  Wydane: (2013)
• Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
  od: Liu, Ning-Ai, i wsp.
  Wydane: (2011)
• Pituitary Somatostatin Receptor Signaling
  od: Ben-Shlomo, Anat, i wsp.
  Wydane: (2010)